Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone-like proteins, primarily represented by the HU (Heat-unstable) protein family, are small, basic, DNA-binding proteins that serve as the primary architectural components of the bacterial nucleoid. They are functional analogs to eukaryotic histones, responsible for compacting the bacterial chromosome through DNA bending, wrapping, and the induction of negative supercoiling. Beyond their structural role, these proteins act as global transcriptional regulators that modulate the expression of genes essential for virulence, metabolism, and adaptation to environmental stress. In many pathogenic species, such as Mycobacterium tuberculosis and Vibrio cholerae, histone-like proteins are indispensable for survival and the development of drug-tolerant subpopulations. Additionally, they are critical for the integrity of biofilms, where they stabilize the lattice of extracellular DNA (eDNA) within the matrix. Therapeutic approaches currently under investigation include monoclonal antibodies that disrupt biofilm structures and small-molecule inhibitors that target the protein's DNA-binding or dimerization interfaces. Because these proteins are structurally distinct from human histones, they are considered high-value targets for the development of novel, narrow-spectrum antimicrobial therapies.
Inhibition of DNA binding, disruption of protein dimerization, perturbation of nucleoid architecture, and destabilization of the extracellular biofilm matrix.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone-like protein (HU).